» Articles » PMID: 39633192

Applied Body-fluid Analysis by Wearable Devices

Abstract

Wearable sensors are a recent paradigm in healthcare, enabling continuous, decentralized, and non- or minimally invasive monitoring of health and disease. Continuous measurements yield information-rich time series of physiological data that are holistic and clinically meaningful. Although most wearable sensors were initially restricted to biophysical measurements, the next generation of wearable devices is now emerging that enable biochemical monitoring of both small and large molecules in a variety of body fluids, such as sweat, breath, saliva, tears and interstitial fluid. Rapidly evolving data analysis and decision-making technologies through artificial intelligence has accelerated the application of wearables around the world. Although recent pilot trials have demonstrated the clinical applicability of these wearable devices, their widespread adoption will require large-scale validation across various conditions, ethical consideration and sociocultural acceptance. Successful translation of wearable devices from laboratory prototypes into clinical tools will further require a comprehensive transitional environment involving all stakeholders. The wearable device platforms must gain acceptance among different user groups, add clinical value for various medical indications, be eligible for reimbursements and contribute to public health initiatives. In this Perspective, we review state-of-the-art wearable devices for body-fluid analysis and their translation into clinical applications, and provide insight into their clinical purpose.

Citing Articles

Biomarkers of inflammation in sweat after myocardial infarction.

Bjorkenheim A, Sunnefeldt E, Finke K, Smith D, Frobert O, Brasier N Sci Rep. 2025; 15(1):5564.

PMID: 39955425 PMC: 11829942. DOI: 10.1038/s41598-025-90240-8.


Towards device technologies non-invasive to our daily lives.

Yoon H, Dagdeviren C Nat Commun. 2025; 16(1):1027.

PMID: 39863577 PMC: 11762694. DOI: 10.1038/s41467-025-56423-7.

References
1.
Rizas K, Freyer L, Sappler N, von Stulpnagel L, Spielbichler P, Krasniqi A . Smartphone-based screening for atrial fibrillation: a pragmatic randomized clinical trial. Nat Med. 2022; 28(9):1823-1830. DOI: 10.1038/s41591-022-01979-w. View

2.
Brasier N, Raichle C, Dorr M, Becke A, Nohturfft V, Weber S . Detection of atrial fibrillation with a smartphone camera: first prospective, international, two-centre, clinical validation study (DETECT AF PRO). Europace. 2018; 21(1):41-47. PMC: 6321964. DOI: 10.1093/europace/euy176. View

3.
Kim J, Campbell A, de Avila B, Wang J . Wearable biosensors for healthcare monitoring. Nat Biotechnol. 2019; 37(4):389-406. PMC: 8183422. DOI: 10.1038/s41587-019-0045-y. View

4.
Tu C, Caudal A, Liu Y, Gorgodze N, Zhang H, Lam C . Tachycardia-induced metabolic rewiring as a driver of contractile dysfunction. Nat Biomed Eng. 2023; 8(4):479-494. PMC: 11088531. DOI: 10.1038/s41551-023-01134-x. View

5.
Concannon T, Grant S, Welch V, Petkovic J, Selby J, Crowe S . Practical Guidance for Involving Stakeholders in Health Research. J Gen Intern Med. 2018; 34(3):458-463. PMC: 6420667. DOI: 10.1007/s11606-018-4738-6. View